89.
[]. Furuta Y, et al. T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections. Antiviral Res. 009 Jun;8(3):95-0.
[]. Hideki Tani, et al. Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus.
[3]. Huchting J, et al. Cell line-dependent activation and antiviral activity of T-05, the non-fluorinated analogue of T-705 (favipiravir). Antiviral Res. 09 Jul;67:-5.
[]. Johanna Huchting, et al. Cell line-dependent activation and antiviral activity of T-05, the non-fluorinated analogue of T-705 (favipiravir). Antiviral Res. 09 Jul;67:-5.
[5]. Lei Cai, et al. Viral polymerase inhibitors T-705 and T-05 are potential inhibitors of Zika virus replication. Arch Virol. 07 Sep;6(9):87-853.
H30-H35-H39-H335
P6-P6-P70-P7-P80-P30+P35-P30+P30-P305+P35+P338-P330-P36+P36-P03+P33-P05-P50